POLICY ON RESEARCH INVOLVING HUMAN SUBJECTS

CIA-STARGATE

PDF Scan: PDF

Open AI Summary

This document is an approved policy from the Defense Technology Group regarding research involving human subjects. The policy states that all research activities involving human subjects must comply with the United States Government federal policy for the protection of human subjects. The policy defines terms such as research, human subject, IRB (Institutional Review Board), minimal risk, principal investigator, and informed consent. The policy also outlines specific actions that need to be taken when proposing research involving human subjects, such as preparing a research protocol, establishing an IRB, obtaining IRB approval, reporting any unanticipated problems, and designating a company representative for each IRB.

Text

Body:  Approved For Release 2000/08/09 : CIA-RDP96-00792R000600170002-2
 Policy on Research Involving Human Subjects
 1.    Introduction. Group activities may from time to time include research involving human
 subjects. This memorandum sets forth Defense Technology Group policy for these
 activities.
 2.    General. It is the policy of the Group to conduct research activities involving human
 subjects so as in every'"way to be in compliance with United States Government federal
 policy for the protection of human subjects, as set forth in the Federal Register, Volume
 56, No. 117, June 18, 1991. This policy applies to all Group research activities involving
 human subjects, regardless of the sponsoring organization.
 3.    Definitions
 a.    Research: A systematic investigation, including Research development, testing,
 and evaluation, designed to develop or contribute to generalizable knowledge.
 b.    Human Subject:  A living individual about whom an investigator conducting
 research obtains data through intervention or interactions with the individual, or
 identifiable private information.
 c.    IRB:  An Institutional Review Board established in accord with and for the
 purposes expressed in this policy.
 d.    Minimal Risk: The probability and magnitude of harm or discomfort anticipated
 in the research are not greater in and of themselves. than those ordinarily
 encountered in daily life or during the performance of routine physical or
 psychological examinations or tests.
 e.    Principal Investigator: The scientist responsible for the planning, execution and
 reporting of the research.
 f.    Informed Consent: Written consent to participate in the research provided by each
 research subject after receiving extensive information outlined in the Federal
 Register (cited above).
 4.     Specific. When Group activity is proposed which includes research involving human
 subjects, the following actions will be accomplished:
 a.    The principal investigator will prepare a research protocol which at a minimum
 will set forth research objectives, experimental design, methodology for data
 collection and analysis, scientific background pertinent to the research, description
 of the research subjects including number, age, gender, recruitment source and
 recruitment procedure, and such other information as may be needed to make a
 Approved For Release 2000/08/09 : CIA-RDP96-00792R000600170002-2
 Approved For Release 2000/08/09 : CIA-RDP96-00792R000600170002-2
 judgement of degree of risk to the research subjects and of the benefits to be
 derived from the research.
 b.    A IRB will be established in accord with federal policy that is competent to
 review the research to be conducted:
 (1)   The IRB will be composed of at least 5 members; membership will include
 both men and women, and at least one person who is not an employee of the
 Company; no member may be associated in any way with the proposed research,
 nor may be a subordinate of the principal investigator, the majority of members
 must reside in the state, or states adjacent to, where the research will be
 conducted, and to reflect local community attitudes.
 (2)   The IRB will receive research protocols in advance of each meeting and
 will review them based on the following criteria: risks are minimized; risks are
 reasonable in relation to anticipated benefits; selection of subjects is equitable;
 informed consent will be obtained and documented; the experimental design is
 sound for the research questions being posed; and the research plan provides for
 the safety and confidentiality of the subjects.
 (3)   The IRB may approve or disapprove research protocols; it may also
 withhold approval pending additional information being provided or changes being
 made in protocol, thus serving as a quality control on compliance with this policy.
 (4)   The IRB will meet at least annually and will receive at least an annual
 report of progress on each approved protocol, thus serving as a quality control on
 compliance with this policy.
 (5)   The IRB will receive for review and approval notification of any change
 to the approved protocol before the change is implemented.
 (6)   The IRB has authority to suspend or terminate research not being
 conducted in accord with the approved protocol.
 (7)   The IRB will have staff support to maintain records of its proceedings.
 c.     No Research involving human subjects will be undertaken without IRB approval.
 d.     Any unanticipated problems involving risks to subjects or others will be reported
 promptly to the IRB.
 e.     The Group Manager will designate a Company representative for each IRB who
 will receive the results of IRB deliberations and will transmit those results to the
 principal investigator.
 tuwj'a~~~~
 Group Manager
 Approved For Release 2000/08/09 : CIA-RDP96-00792R000600170002-2